z-logo
Premium
Nutrition Management of Amyotrophic Lateral Sclerosis
Author(s) -
Greenwood Daniel I.
Publication year - 2013
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0884533613476554
Subject(s) - medicine , malnutrition , percutaneous endoscopic gastrostomy , dysphagia , parenteral nutrition , gastrostomy , feeding tube , weight loss , enteral administration , amyotrophic lateral sclerosis , intensive care medicine , depression (economics) , pediatrics , disease , surgery , obesity , finance , peg ratio , economics , macroeconomics
Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease with high risk of malnutrition. Symptoms of dysphagia, depression, cognitive impairment, difficulty with self‐feeding and meal preparation, hypermetabolism, anxiety, respiratory insufficiency, and fatigue with meals increase the risk of malnutrition. Malnutrition negatively affects prognosis and quality of life, making early and frequent nutrition assessment and intervention essential. Implementation of an adequate calorie diet, dietary texture modification, use of adaptive eating utensils, and placement of a feeding tube aid in preventing malnutrition. When nutrition status is compromised by dysphagia and weight loss (5%–10% of usual body weight) or body mass index <20 kg/m 2 without weight loss and when forced vital capacity is >50%, a percutaneous endoscopic gastrostomy placement is indicated. When forced vital capacity is <50%, a radiologically inserted gastrostomy is the preferred means of enteral placement due to lessened aspiration and respiratory risk. Parenteral nutrition (PN) is indicated only when enteral nutrition (EN) is contraindicated or impossible. This article reviews the background of ALS, nutrition implications and risk of malnutrition, treatment strategies to prevent malnutrition, the role of EN and PN, and feeding tube placement methods according to disease stage.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here